HK academic leads local team in the First Global CDK4/6i Trial Exclusively on Premenopausal Women

To enhance the public awareness of the new therapy significantly prolongs lives of young women with HR+/HER2- advanced breast cancer, a press event is organized in late July, 2019 at Hong Kong. During the event, Professor Winnie Yeo, Vice President of Hong Kong Breast Oncology Group presented the findings in the MONALEESA-7 study. As a result, more than 12 media has covered the news which generated significantly outcomes.


Event Management, Media Publicity